Detalles de la búsqueda
1.
Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trial.
Diabetes Obes Metab
; 26(1): 201-214, 2024 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-37846555
2.
Women with prior gestational diabetes mellitus and prediabetes are characterised by a decreased incretin effect.
Diabetologia
; 60(7): 1344-1353, 2017 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-28364253
3.
Involvement of glucagon-like peptide-1 in the glucose-lowering effect of metformin.
Diabetes Obes Metab
; 18(10): 955-61, 2016 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-27265206
4.
Colesevelam has no acute effect on postprandial GLP-1 levels but abolishes gallbladder refilling.
Eur J Endocrinol
; 190(4): 314-326, 2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38551029
5.
One Year's Treatment with the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide Decreases Hepatic Fat Content in Women with Nonalcoholic Fatty Liver Disease and Prior Gestational Diabetes Mellitus in a Randomized, Placebo-Controlled Trial.
J Clin Med
; 9(10)2020 Oct 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33036179
6.
[Metformin is a possible glucagon-like peptide 1 stimulator].
Ugeskr Laeger
; 180(12)2018 Mar 19.
Artículo
en Da
| MEDLINE | ID: mdl-29559078
7.
Metformin-induced glucagon-like peptide-1 secretion contributes to the actions of metformin in type 2 diabetes.
JCI Insight
; 3(23)2018 12 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30518693
8.
Nonalcoholic Fatty Liver Disease Is Prevalent in Women With Prior Gestational Diabetes Mellitus and Independently Associated With Insulin Resistance and Waist Circumference.
Diabetes Care
; 40(1): 109-116, 2017 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-27810989
Resultados
1 -
8
de 8
1
Próxima >
>>